S
DGX icon

Sachetta’s Quest Diagnostics DGX Stock Holding History

Sachetta’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$19.6K – 1077
2026
Q1 		$19.6K Sell
100
-14
-12% -$2.72K 0.01% 312
2025
Q4 		$19.8K Hold
114
– – 0.01% 295
2025
Q3 		$21.7K Sell
114
-88
-44% -$15.6K 0.01% 349
2025
Q2 		$36.3K Hold
202
– – 0.01% 292
2025
Q1 		$34.2K Sell
202
-251
-55% -$41.2K 0.01% 291
2024
Q4 		$68.3K Sell
453
-46
-9% -$7.16K 0.03% 234
2024
Q3 		$77.5K Hold
499
– – 0.03% 224
2024
Q2 		$71.3K Sell
499
-165
-25% -$22.6K 0.03% 218
2024
Q1 		$91.6K Hold
664
– – 0.04% 193
2023
Q4 		$91.6K Buy
+664
New +$87.3K 0.04% 193

Other funds holding DGX

EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.11B AUM 35.22% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sachetta's DGX Position: Q2 2026 in Review

Sachetta sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 100 shares — an estimated $19.6K sold.

Sachetta first reported a position in DGX in Q4 2023 and held it in 10 quarters. The position peaked at $91.6K in Q1 2024. 182 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Sachetta reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 100 Quest Diagnostics shares in Q2 2026, an estimated $19.6K.
  • Sachetta first reported a position in Quest Diagnostics in Q4 2023 and held it in 10 quarters.
  • Sachetta's Quest Diagnostics position peaked at $91.6K in Q1 2024.
  • 182 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.